Titre : Syndrome de détresse respiratoire de l'adulte

Syndrome de détresse respiratoire de l'adulte : Questions médicales fréquentes

Termes MeSH sélectionnés :

Guidelines as Topic
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Syndrome de détresse respiratoire de l'adulte : Questions médicales les plus fréquentes", "headline": "Syndrome de détresse respiratoire de l'adulte : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Syndrome de détresse respiratoire de l'adulte : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-24", "dateModified": "2025-03-19", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Syndrome de détresse respiratoire de l'adulte" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Troubles respiratoires", "url": "https://questionsmedicales.fr/mesh/D012120", "about": { "@type": "MedicalCondition", "name": "Troubles respiratoires", "code": { "@type": "MedicalCode", "code": "D012120", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C08.618" } } }, "about": { "@type": "MedicalCondition", "name": "Syndrome de détresse respiratoire de l'adulte", "alternateName": "Respiratory Distress Syndrome", "code": { "@type": "MedicalCode", "code": "D012128", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Lorraine B Ware", "url": "https://questionsmedicales.fr/author/Lorraine%20B%20Ware", "affiliation": { "@type": "Organization", "name": "Departments of Medicine and Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA." } }, { "@type": "Person", "name": "Tariq Cheema", "url": "https://questionsmedicales.fr/author/Tariq%20Cheema", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Carolyn S Calfee", "url": "https://questionsmedicales.fr/author/Carolyn%20S%20Calfee", "affiliation": { "@type": "Organization", "name": "Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Departments of Medicine and Anesthesia, University of California San Francisco, San Francisco, CA, USA." } }, { "@type": "Person", "name": "Michael A Matthay", "url": "https://questionsmedicales.fr/author/Michael%20A%20Matthay", "affiliation": { "@type": "Organization", "name": "Departments of Medicine and Anesthesia, University of California San Francisco, San Francisco, CA, USA." } }, { "@type": "Person", "name": "Nuala J Meyer", "url": "https://questionsmedicales.fr/author/Nuala%20J%20Meyer", "affiliation": { "@type": "Organization", "name": "Pulmonary, Allergy and Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia, PA, USA. Electronic address: nuala.meyer@pennmedicine.upenn.edu." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Nonpharmacologic and Pharmacologic Treatments of Adult Patients With Major Depressive Disorder: A Systematic Review and Network Meta-analysis for a Clinical Guideline by the American College of Physicians.", "datePublished": "2023-01-24", "url": "https://questionsmedicales.fr/article/36689750", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.7326/M22-1845" } }, { "@type": "ScholarlyArticle", "name": "Trends in Venous Thromboembolism After Shoulder Arthroplasty in the United States: Analysis Following the 2009 American Academy of Orthopaedic Surgeons Clinical Practical Guidelines.", "datePublished": "2023-01-19", "url": "https://questionsmedicales.fr/article/36727919", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.5435/JAAOS-D-22-00825" } }, { "@type": "ScholarlyArticle", "name": "Recommendations for improving maternal health services in Indonesian primary care under the COVID-19 pandemic: Results of a systematic review and appraisal of international guidelines.", "datePublished": "2023-01-12", "url": "https://questionsmedicales.fr/article/36669234", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.srhc.2023.100811" } }, { "@type": "ScholarlyArticle", "name": "Non-acute chest pain in primary care; referral rates, communication and guideline adherence: a cohort study using routinely collected health data.", "datePublished": "2022-12-22", "url": "https://questionsmedicales.fr/article/36550420", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12875-022-01939-w" } }, { "@type": "ScholarlyArticle", "name": "AGIHO guideline on evidence-based management of COVID-19 in cancer patients: 2022 update on vaccination, pharmacological prophylaxis and therapy in light of the omicron variants.", "datePublished": "2022-12-10", "url": "https://questionsmedicales.fr/article/36652889", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ejca.2022.11.030" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies de l'appareil respiratoire", "item": "https://questionsmedicales.fr/mesh/D012140" }, { "@type": "ListItem", "position": 3, "name": "Troubles respiratoires", "item": "https://questionsmedicales.fr/mesh/D012120" }, { "@type": "ListItem", "position": 4, "name": "Syndrome de détresse respiratoire de l'adulte", "item": "https://questionsmedicales.fr/mesh/D012128" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Syndrome de détresse respiratoire de l'adulte - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Syndrome de détresse respiratoire de l'adulte", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-02", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Syndrome de détresse respiratoire de l'adulte", "description": "Comment diagnostique-t-on le SDRA ?\nQuels examens sont utilisés pour le SDRA ?\nQuels critères sont utilisés pour le SDRA ?\nLe SDRA peut-il être confondu avec d'autres maladies ?\nQuels signes cliniques indiquent le SDRA ?", "url": "https://questionsmedicales.fr/mesh/D012128?mesh_terms=Guidelines+as+Topic&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Syndrome de détresse respiratoire de l'adulte", "description": "Quels sont les symptômes du SDRA ?\nLe SDRA provoque-t-il de la toux ?\nComment se manifeste l'hypoxie dans le SDRA ?\nLe SDRA entraîne-t-il des douleurs thoraciques ?\nY a-t-il des signes d'anxiété avec le SDRA ?", "url": "https://questionsmedicales.fr/mesh/D012128?mesh_terms=Guidelines+as+Topic&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Syndrome de détresse respiratoire de l'adulte", "description": "Comment prévenir le SDRA ?\nLe sevrage tabagique aide-t-il à prévenir le SDRA ?\nLes vaccinations peuvent-elles prévenir le SDRA ?\nLe contrôle des maladies chroniques aide-t-il ?\nLes soins postopératoires peuvent-ils prévenir le SDRA ?", "url": "https://questionsmedicales.fr/mesh/D012128?mesh_terms=Guidelines+as+Topic&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Syndrome de détresse respiratoire de l'adulte", "description": "Quels traitements sont disponibles pour le SDRA ?\nLe SDRA nécessite-t-il une hospitalisation ?\nLes corticostéroïdes sont-ils utilisés pour le SDRA ?\nLa ventilation non invasive est-elle efficace pour le SDRA ?\nLe SDRA peut-il être traité par des médicaments ?", "url": "https://questionsmedicales.fr/mesh/D012128?mesh_terms=Guidelines+as+Topic&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Syndrome de détresse respiratoire de l'adulte", "description": "Quelles sont les complications du SDRA ?\nLe SDRA peut-il entraîner des séquelles ?\nLe SDRA augmente-t-il le risque de décès ?\nQuelles infections peuvent survenir avec le SDRA ?\nLe SDRA peut-il causer des problèmes cardiaques ?", "url": "https://questionsmedicales.fr/mesh/D012128?mesh_terms=Guidelines+as+Topic&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Syndrome de détresse respiratoire de l'adulte", "description": "Quels sont les facteurs de risque du SDRA ?\nL'âge influence-t-il le risque de SDRA ?\nLe tabagisme est-il un facteur de risque ?\nLes maladies pulmonaires chroniques augmentent-elles le risque ?\nLes interventions chirurgicales augmentent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D012128?mesh_terms=Guidelines+as+Topic&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on le SDRA ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le SDRA est diagnostiqué par des examens cliniques, radiographies et tests de gaz du sang." } }, { "@type": "Question", "name": "Quels examens sont utilisés pour le SDRA ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les radiographies thoraciques et les tomodensitométries sont couramment utilisées." } }, { "@type": "Question", "name": "Quels critères sont utilisés pour le SDRA ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les critères de Berlin classifient le SDRA en léger, modéré et sévère selon l'hypoxie." } }, { "@type": "Question", "name": "Le SDRA peut-il être confondu avec d'autres maladies ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut être confondu avec des pneumonies ou des embolies pulmonaires." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent le SDRA ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent une respiration rapide, une cyanose et une détresse respiratoire." } }, { "@type": "Question", "name": "Quels sont les symptômes du SDRA ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent une dyspnée, une tachypnée et une hypoxie sévère." } }, { "@type": "Question", "name": "Le SDRA provoque-t-il de la toux ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une toux sèche peut être présente, mais elle n'est pas toujours significative." } }, { "@type": "Question", "name": "Comment se manifeste l'hypoxie dans le SDRA ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "L'hypoxie se manifeste par une saturation en oxygène faible et une cyanose." } }, { "@type": "Question", "name": "Le SDRA entraîne-t-il des douleurs thoraciques ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs thoraciques peuvent survenir, mais elles ne sont pas toujours présentes." } }, { "@type": "Question", "name": "Y a-t-il des signes d'anxiété avec le SDRA ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'anxiété peut être présente en raison de la difficulté à respirer." } }, { "@type": "Question", "name": "Comment prévenir le SDRA ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par la gestion des facteurs de risque et le traitement précoce des infections." } }, { "@type": "Question", "name": "Le sevrage tabagique aide-t-il à prévenir le SDRA ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, arrêter de fumer réduit le risque de complications pulmonaires, y compris le SDRA." } }, { "@type": "Question", "name": "Les vaccinations peuvent-elles prévenir le SDRA ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les vaccinations contre la grippe et le pneumocoque peuvent réduire le risque." } }, { "@type": "Question", "name": "Le contrôle des maladies chroniques aide-t-il ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un bon contrôle des maladies chroniques comme l'asthme peut aider à prévenir le SDRA." } }, { "@type": "Question", "name": "Les soins postopératoires peuvent-ils prévenir le SDRA ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des soins postopératoires appropriés peuvent réduire le risque de SDRA après une chirurgie." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour le SDRA ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement inclut l'oxygénothérapie, la ventilation mécanique et le traitement de la cause sous-jacente." } }, { "@type": "Question", "name": "Le SDRA nécessite-t-il une hospitalisation ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la plupart des cas de SDRA nécessitent une hospitalisation en soins intensifs." } }, { "@type": "Question", "name": "Les corticostéroïdes sont-ils utilisés pour le SDRA ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les corticostéroïdes peuvent réduire l'inflammation dans certains cas de SDRA." } }, { "@type": "Question", "name": "La ventilation non invasive est-elle efficace pour le SDRA ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut être efficace dans les cas légers, mais la ventilation invasive est souvent nécessaire." } }, { "@type": "Question", "name": "Le SDRA peut-il être traité par des médicaments ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments peuvent être utilisés pour traiter la cause sous-jacente, mais pas le SDRA directement." } }, { "@type": "Question", "name": "Quelles sont les complications du SDRA ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'insuffisance respiratoire, les infections et les lésions pulmonaires." } }, { "@type": "Question", "name": "Le SDRA peut-il entraîner des séquelles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des séquelles pulmonaires peuvent persister après la guérison du SDRA." } }, { "@type": "Question", "name": "Le SDRA augmente-t-il le risque de décès ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le SDRA a un taux de mortalité élevé, surtout dans les cas sévères." } }, { "@type": "Question", "name": "Quelles infections peuvent survenir avec le SDRA ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les infections pulmonaires, comme la pneumonie, sont fréquentes chez les patients atteints de SDRA." } }, { "@type": "Question", "name": "Le SDRA peut-il causer des problèmes cardiaques ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le SDRA peut entraîner des complications cardiaques en raison de l'hypoxie prolongée." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque du SDRA ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent les infections, les traumatismes, la pneumonie et les maladies chroniques." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque de SDRA ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées ont un risque accru de développer un SDRA." } }, { "@type": "Question", "name": "Le tabagisme est-il un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme augmente le risque de complications pulmonaires et de SDRA." } }, { "@type": "Question", "name": "Les maladies pulmonaires chroniques augmentent-elles le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme la BPCO augmentent le risque de développer un SDRA." } }, { "@type": "Question", "name": "Les interventions chirurgicales augmentent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines interventions chirurgicales, surtout thoraciques, peuvent augmenter le risque de SDRA." } } ] } ] }

Sources (10000 au total)

Nonpharmacologic and Pharmacologic Treatments of Adult Patients With Major Depressive Disorder: A Systematic Review and Network Meta-analysis for a Clinical Guideline by the American College of Physicians.

Primary care patients and clinicians may prefer alternative options to second-generation antidepressants for major depressive disorder (MDD).... To compare the benefits and harms of nonpharmacologic treatments with second-generation antidepressants as first-step interventions for acute MDD, and to compare second-step treatment strategies for p... English-language studies from several electronic databases from 1 January 1990 to 8 August 2022, trial registries, gray literature databases, and reference lists to identify unpublished research.... 2 investigators independently selected randomized trials of at least 6 weeks' duration.... Reviewers abstracted data about study design and conduct, participants, interventions, and outcomes. They dually rated the risk of bias of studies and the certainty of evidence for outcomes of interes... 65 randomized trials met the inclusion criteria; eligible data from nonrandomized studies were not found. Meta-analyses and network meta-analyses indicated similar benefits of most nonpharmacologic tr... Many studies had methodological limitations or dosing inequalities; publication bias might have affected some comparisons. In some cases, conclusions could not be drawn because of insufficient evidenc... Although benefits seem to be similar among first- and second-step MDD treatments, the certainty of evidence is low for most comparisons. Clinicians and patients should focus on options with the most r... American College of Physicians. (PROSPERO: CRD42020204703)....

Trends in Venous Thromboembolism After Shoulder Arthroplasty in the United States: Analysis Following the 2009 American Academy of Orthopaedic Surgeons Clinical Practical Guidelines.

In 2009, the American Academy of Orthopaedic Surgeons released a consensus recommending venous thromboembolism (VTE) prophylaxis after total shoulder arthroplasty (TSA). The purpose of this study was ... Using the PearlDiver database, national data from 2010 to 2019 were used to identify patients who underwent primary TSA for osteoarthritis and/or rotator cuff arthropathy. Exclusions entailed liver pa... From 2010 to 2019, there was a reduction in VTE rates from 0.89% in 2010 to 0.78% in 2019. Regarding implant type, there was no notable change in incidence of VTE, DVT, and pulmonary embolism within 9... The incidence and economic burden associated with VTE after TSA have markedly declined following the 2010 American Academy of Orthopaedic Surgeons clinical practice guidelines. This reduction can be a... Therapeutic, III....

Recommendations for improving maternal health services in Indonesian primary care under the COVID-19 pandemic: Results of a systematic review and appraisal of international guidelines.

A large volume of evidence and reviews about COVID-19 recommendations have been published; however, only a few provide recommendations on maternal health services ready for their adoption in Indonesia... A literature search to identify articles that cover a set of recommendations, or maternal guideline under the SARS-COV-1 outbreak or COVID-19 pandemic that were published from 2020 to 1 November 2022 ... Fourteen guidelines were fully reviewed, and most of them had high AGREE II scores. Two main themes emerged from the analysis: clinical and supporting arrangements for maternal health services. Potent... Potential recommendations for improving maternal health for women in Indonesia under the COVID-19 pandemic both on the clinical and supporting services arrangements have been identified. Available cli...

Non-acute chest pain in primary care; referral rates, communication and guideline adherence: a cohort study using routinely collected health data.

The prevalence of coronary artery disease is increasing due to the aging population and increasing prevalence of cardiovascular risk factors. Non-acute chest pain often is the first symptom of stable ... We used routinely collected health data from the STIZON data warehouse in the Netherlands between 2010 and 2016. Patients > 18 years, with no history of cardiovascular disease, seen by the general pra... In total 9029 patients were included during the study period, resulting in an incidence of new non-acute chest pain of 1.01/1000 patient-years. 2166 (24%) patients were referred to the cardiologist. I... After referral, both communication from cardiologists and registration of the final diagnosis by GPs were suboptimal. Both cardiologists and GPs should make adequate communication and registration a p...

AGIHO guideline on evidence-based management of COVID-19 in cancer patients: 2022 update on vaccination, pharmacological prophylaxis and therapy in light of the omicron variants.

The novel coronavirus SARS-CoV-2 and the associated infectious disease COVID-19 pose a significant challenge to healthcare systems worldwide. Patients with cancer have been identified as a high-risk p...

Use of the knowledge to action model improved physical therapist adherence to a common clinical practice guideline across multiple settings: a multisite case series.

When a new guideline is published there is a need to understand how its recommendations can best be implemented in real-world practice. Yet, guidelines are often published with little to no roadmap fo... Five organizationally distinct sites with physical therapy services for patients with peripheral vestibular hypofunction participated. The Knowledge to Action model served as the foundation for implem... Therapist participants at all sites indicated readiness for change and commitment to the project. Four sites with more experienced therapists selected similar target behaviors while the fifth, with mo... The Knowledge to Action model provided a common process model for sites with diverse structures and needs to implement a guideline in practice. Multimodal, active interventions, with a focus on auditi... This study does not report the results of a health care intervention on human participants....

Sequencing and titrating approach of therapy in heart failure with reduced ejection fraction following the 2021 European Society of Cardiology guidelines: an international cardiology survey.

In symptomatic patients with heart failure and reduced ejection fraction (HFrEF), recent international guidelines recommend initiating four major therapeutic classes rather than sequential initiation.... An independent academic web-based survey was designed by a group of HF specialists and posted by email and through various social networks to a broad community of cardiologists worldwide 1 year after ... In a broad international cardiology community, the 'historical approach' to HFrEF therapies remains the preferred sequencing approach. However, accelerated introduction and uptitration are also major ...

Characteristics and Outcomes of Cardiac Arrest in Adult Patients Admitted to Pediatric Services: A Descriptive Analysis of the American Heart Association's Get With The Guidelines-Resuscitation Data.

Differences between adult and pediatric in-hospital cardiac arrest (IHCA) are well-described. Although most adults are cared for on adult services, pediatric services often admit adults, particularly ... Retrospective cohort analysis from the American Heart Association's Get With The Guidelines-Resuscitation registry of a subpopulation of adults with IHCA while admitted to pediatric services. Multivar... Hospitals contributing to the Get With The Guidelines-Resuscitation registry.... Adult-aged patients (≥ 18 yr) with an index pulseless IHCA while admitted to a pediatric service from 2000 to 2018.... None.... A total of 491 adult IHCAs were recorded on pediatric services at 17 sites, during the 19 years of review, and these events represented 0.1% of all adult IHCAs. In total, 221 cases met inclusion crite... In this cohort of adults with IHCA while admitted to a pediatric service, we failed to find an association between survival outcomes and age. Additional research is needed to better understand resusci...

Joint EANM/SNMMI guideline on radiomics in nuclear medicine : Jointly supported by the EANM Physics Committee and the SNMMI Physics, Instrumentation and Data Sciences Council.

The purpose of this guideline is to provide comprehensive information on best practices for robust radiomics analyses for both hand-crafted and deep learning-based approaches.... In a cooperative effort between the EANM and SNMMI, we agreed upon current best practices and recommendations for relevant aspects of radiomics analyses, including study design, quality assurance, dat... Radiomics is a very quickly evolving field of research. The present guideline focused on established findings as well as recommendations based on the state of the art. Though this guideline recognizes...

Demands on Health Information and Clinical Practice Guidelines for Patients from the Perspective of Adults with Mental Illness and Family Members: A Qualitative Study with In-Depth Interviews.

(1) Background: "Patient health information" promote health literacy. "Patient guidelines" as a sub group reflect the current evidence about illnesses and treatment options adapted to the needs of lay...